Development of an Electrochemical Method to Study Real-Time in Vivo Neurotransmitter Modulation

Histamine and serotonin are important biogenic amines that regulate vital brain functions. These two transmitters are thoughts to be involved in neurodegenerative diseases such as Parkinson’s and Alzheimer’s and affective disorders including depression. Histamine and serotonin are believed to regulate each other but their fundamental neuromodulation mechanisms are not well understood. This lack of understanding makes brain disorders implicating these two transmitters difficult to diagnose and treat. Our lab extensively investigates the serotonergic system to understand serotonin’s neurochemistry in the brain. However, histamine is relatively understudied with respect to other biogenic amines because of an absence of suitable analytical tools. This work introduces a strategic approach to overcome this analytical challenge and investigates the real-time neuromodulation of in vivo histamine and serotonin to understand physiological functions in healthy and disease states using fast-scan cyclic voltammetry (FSCV). First, we perform a proof-of-principle study of Copper (Cu(II)) analysis to characterize the adsorption driven FSCV response. Next, we employ FSCV to develop a novel voltammetric method to selectively and sensitively monitor real-time in vivo histamine and serotonin neurotransmissions in the posterior hypothalamus (PH). This study reveals that histamine inhibits serotonin via an H3 receptor mediated process, highlighting histamine’s roles in regulating serotonin release in the brain. Following that, we examine histamine’s reuptake mechanisms via monoamine transporter proteins and demonstrate that histamine uptake mechanism is mediated by organic cation transporters.Finally, we use our novel FSCV method to monitor histamine and serotonin neurotransmissions in HIV- 1 Tg rats, which exhibit neuroinflammation, to understand impaired neurochemical mechanisms in the disease state. Collectively, this dissertation showcases a novel and robust electroanalytical strategy to simultaneously monitor in vivo histamine and serotonin neuromodulation in real time. Innovative discoveries in this systematic investigation of the histaminergic regulation of serotonin in diverse neurochemical and pathophysiological processes will pave the way towards more efficient therapies for histamine and serotonin related brain disorders

Enhanced Mutant Compensates for Defects in Rhodopsin Phosphorylation in the Presence of Endogenous Arrestin-1

We determined the effects of different expression levels of arrestin-1-3A mutant with enhanced binding to light-activated rhodopsin that is independent of phosphorylation. To this end, transgenic mice that express mutant rhodopsin with zero, one, or two phosphorylation sites, instead of six in the WT mouse rhodopsin, and normal complement of WT arrestin-1, were bred with mice expressing enhanced phosphorylation-independent arrestin-1-3A mutant. The resulting lines were characterized by retinal histology (thickness of the outer nuclear layer, reflecting the number of rod photoreceptors, and the length of the outer segments, which reflects rod health), as well as single- and double-flash ERG to determine the functionality of rods and the rate of photoresponse recovery. The effect of co-expression of enhanced arrestin-1-3A mutant with WT arrestin-1 in these lines depended on its level: higher (240% of WT) expression reduced the thickness of ONL and the length of OS, whereas lower (50% of WT) expression was harmless in the retinas expressing rhodopsin with zero or one phosphorylation site, and improved photoreceptor morphology in animals expressing rhodopsin with two phosphorylation sites. Neither expression level increased the amplitude of the a- and b-wave of the photoresponse in any of the lines. However, high expression of enhanced arrestin-1-3A mutant facilitated photoresponse recovery 2-3-fold, whereas lower level was ineffective. Thus, in the presence of normal complement of WT arrestin-1 only supra-physiological expression of enhanced mutant is sufficient to compensate for the defects of rhodopsin phosphorylation

Biological Role of Arrestin-1 Oligomerization

Members of the arrestin superfamily have great propensity of self-association, but the physiological significance of this phenomenon is unclear. To determine the biological role of visual arrestin-1 oligomerization in rod photoreceptors, we expressed mutant arrestin-1 with severely impaired self-association in mouse rods and analyzed mice of both sexes. We show that the oligomerization-deficient mutant is capable of quenching rhodopsin signaling normally, as judged by electroretinography and single-cell recording. Like wild type, mutant arrestin-1 is largely excluded from the outer segments in the dark, proving that the normal intracellular localization is not due the size exclusion of arrestin-1 oligomers. In contrast to wild type, supraphysiological expression of the mutant causes shortening of the outer segments and photoreceptor death. Thus, oligomerization reduces the cytotoxicity of arrestin-1 monomer, ensuring long-term photoreceptor survival.SIGNIFICANCE STATEMENT Visual arrestin-1 forms dimers and tetramers. The biological role of its oligomerization is unclear. To test the role of arrestin-1 self-association, we expressed oligomerization-deficient mutant in arrestin-1 knock-out mice. The mutant quenches light-induced rhodopsin signaling like wild type, demonstrating that in vivo monomeric arrestin-1 is necessary and sufficient for this function. In rods, arrestin-1 moves from the inner segments and cell bodies in the dark to the outer segments in the light. Nonoligomerizing mutant undergoes the same translocation, demonstrating that the size of the oligomers is not the reason for arrestin-1 exclusion from the outer segments in the dark. High expression of oligomerization-deficient arrestin-1 resulted in rod death. Thus, oligomerization reduces the cytotoxicity of high levels of arrestin-1 monomer

In Vivo Ambient Serotonin Measurements at Carbon-Fiber Microelectrodes

The mechanisms that control extracellular serotonin levels in vivo are not well-defined. This shortcoming makes it very challenging to diagnose and treat the many psychiatric disorders in which serotonin is implicated. Fast-scan cyclic voltammetry (FSCV) can measure rapid serotonin release and reuptake events but cannot report critically important ambient serotonin levels. In this Article, we use fast-scan controlled adsorption voltammetry (FSCAV), to measure serotonin’s steady-state, extracellular chemistry. We characterize the “Jackson” voltammetric waveform for FSCAV and show highly stable, selective, and sensitive ambient serotonin measurements in vitro. In vivo, we report basal serotonin levels in the CA2 region of the hippocampus as 64.9 ± 2.3 nM (<i>n</i> = 15 mice, weighted average ± standard error). We electrochemically and pharmacologically verify the selectivity of the serotonin signal. Finally, we develop a statistical model that incorporates the uncertainty in in vivo measurements, in addition to electrode variability, to more critically analyze the time course of pharmacological data. Our novel method is a uniquely powerful analysis tool that can provide deeper insights into the mechanisms that control serotonin’s extracellular levels